Real-life studies and registries of severe asthma: The advent of digital technology

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics

(2023) Johannes A. Kroes et al.   ERJ Open Research

Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

(2022) Andrew N Menzies-Gow et al.   Journal of Asthma and Allergy

Biologics in severe asthma: the role of real-world evidence from registries

(2022) Giovanni Paoletti et al.   European Respiratory Review

Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

(2022) Ekaterina Khaleva et al.   EUROPEAN RESPIRATORY JOURNAL

Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study

(2022) Alida Benfante et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CHronic RhINOSinusitis Outcome Registry (CHRINOSOR): establishment of an international outcome registry driven by mHealth technology.

(2022) Sven F. Seys et al.   Journal of Allergy and Clinical Immunology-In Practice

Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes

(2022) S. Peeters et al.   Environmental Health

Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

(2022) Amir Hossein Alizadeh Bahmani et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

(2022) Bernardo Sousa‐Pinto et al.   Clinical and Translational Allergy

Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group

(2022) Eugene R. Bleecker et al.   World Allergy Organization Journal

A large language model for electronic health records

(2022) Xi Yang et al.   npj Digital Medicine

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

(2021) Andrew Menzies-Gow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Exposome mapping in chronic respiratory diseases: the added value of digital technology

(2021) Janne Goossens et al.   Current Opinion in Allergy and Clinical Immunology

Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort

(2020) Katrin Milger et al.   RESPIRATORY MEDICINE

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

(2020) David J Jackson et al.   THORAX

Mobile health tools for the management of chronic respiratory diseases

(2019) Kristien Sleurs et al.   ALLERGY

The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group

(2019) Nicolas Roche et al.   EUROPEAN RESPIRATORY JOURNAL

Characteristics and treatment regimens across ERS SHARP severe asthma registries

(2019) Job J.M.H. van Bragt et al.   EUROPEAN RESPIRATORY JOURNAL

Interactions between Air Pollution and Pollen Season for Rhinitis Using Mobile Technology: A MASK-POLLAR Study

(2019) Annabelle Bédard et al.   Journal of Allergy and Clinical Immunology-In Practice

International Severe Asthma Registry

(2019) G. Walter Canonica et al.   CHEST

Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status

(2019) Alvaro A. Cruz et al.   RESPIRATORY MEDICINE

Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

(2018) J. Bousquet et al.   ALLERGY

Working while unwell: Workplace impairment in people with severe asthma

(2018) S. A. Hiles et al.   CLINICAL AND EXPERIMENTAL ALLERGY

U-BIOPRED: evaluation of the value of a public–private partnership to industry

(2018) John H. Riley et al.   DRUG DISCOVERY TODAY

More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II

(2018) Bradley E. Chipps et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Asthma

(2018) Alberto Papi et al.   LANCET

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age

(2018) W. Gerald Teague et al.   Journal of Allergy and Clinical Immunology-In Practice

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

(2018) Vanessa M. McDonald et al.   RESPIROLOGY

The Severe Asthma Network in Italy: Findings and Perspectives

(2018) Enrico Heffler et al.   Journal of Allergy and Clinical Immunology-In Practice

The Asthma Mobile Health Study, a large-scale clinical observational study using ResearchKit

(2017) Yu-Feng Yvonne Chan et al.   NATURE BIOTECHNOLOGY

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

(2016) P. G. Gibson et al.   INTERNAL MEDICINE JOURNAL

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

(2016) Eugene R Bleecker et al.   LANCET

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

(2016) Sally Wenzel et al.   LANCET

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

(2015) Dominick E. Shaw et al.   EUROPEAN RESPIRATORY JOURNAL

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

(2015) Mario Castro et al.   Lancet Respiratory Medicine

Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II

(2015) Mihaela Teodorescu et al.   Journal of Allergy and Clinical Immunology-In Practice

Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)

(2014) F. Schleich et al.   RESPIRATORY MEDICINE

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry

(2013) Luis Pérez de Llano et al.   JOURNAL OF ASTHMA

Adherence Monitoring and E-Health: How Clinicians and Researchers Can Use Technology to Promote Inhaler Adherence for Asthma

(2013) Amy Hai Yan Chan et al.   Journal of Allergy and Clinical Immunology-In Practice

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

(2012) Bradley E. Chipps et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

(2010) E. H. Bel et al.   THORAX

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry

(2010) L. G. Heaney et al.   THORAX

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

(2009) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE